Published: Fri, May 19, 2017
Money | By Armando Alvarado

Athenahealth, Inc (ATHN) Receives Outperform Rating from Oppenheimer Holdings Inc

Athenahealth, Inc (ATHN) Receives Outperform Rating from Oppenheimer Holdings Inc

Investment analysts at SunTrust Banks dropped their Q2 2017 earnings per share estimates for shares of athenahealth in a research report issued to clients and investors on Wednesday, according to Zacks Investment Research. 3,118,406 shares of the stock traded hands. Stifel Nicolaus cut their target price on shares of athenahealth from $125.00 to $116.00 and set a "hold" rating for the company in a research report on Monday, February 6th. The day's total volume of 3096152 this morning is in contrast from the three-month daily average of 552.72K. On average, analysts anticipate that athenahealth, Inc will post $1.89 EPS for the current fiscal year.

Stock is now moving with a positive distance from the 200 day simple moving average of approximately 13.85%, and has a solid year to date (YTD) performance of 23.68% which means the stock is constantly adding to its value from the previous fiscal year end price. Over the past month the firm's stock is -5.37%, -9.02% for the last quarter, 4.39% for the past six-months and -18.54% for the previous year.

Things to Know About the Chelsea Manning Release
Under this status she will not receive pay but is entitled to medical care at military facilities and other military privileges. One day after sentencing, she came out as a transgender woman, but still had to serve her sentence at the all-male army prison.

Currently, the market capitalization of athenahealth, Inc. The firm's 50 day moving average is $110.87 and its 200-day moving average is $110.59. Following the transaction, the chief executive officer now owns 319,807 shares in the company, valued at $38,376,840. The company had revenue of $285.40 million during the quarter, compared to analyst estimates of $296.49 million. Bank of New York Mellon Corp now owns 329,619 shares of the health services provider's stock worth $41,572,000 after buying an additional 17,290 shares in the last quarter. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Cantor Fitzgerald restated an "outperform" rating and set a $135.00 target price on shares of athenahealth in a research report on Tuesday, January 31st.

On 4/25/2017 Jonathan Bush, CEO, sold 8,000 with an average share price of $120.00 per share and the total transaction amounting to $960,000.00. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of United States & global copyright law. The legal version of this report can be viewed at https://baseballnewssource.com/markets/athenahealth-inc-athn-given-a-95-00-price-target-at-jefferies-group-llc-updated-updated/675044.html. Finally, Arrowpoint Asset Management LLC increased its position in athenahealth by 149.1% in the fourth quarter. Tudor Investment Corp ET AL now owns 7,604 shares of the health services provider's stock valued at $857,000 after buying an additional 3,501 shares during the period. Highbridge Capital Management LLC acquired a new position in shares of athenahealth during the fourth quarter valued at $13,599,000. The disclosure for this sale can be found here. Finally, Neuberger Berman Group LLC raised its position in athenahealth by 10.2% in the third quarter. Credit Suisse AG now owns 300,420 shares of the health services provider's stock valued at $33,854,000 after buying an additional 240,876 shares during the period. The Company also offers Epocrates and other point-of-care mobile applications.

Like this: